Citation Impact
Citing Papers
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
2009
Long-term Cardiovascular Outcomes in Survivors of Kawasaki Disease
2014
Long-Term Prognosis of Patients With Kawasaki Disease Complicated by Giant Coronary Aneurysms
2011
The metabolic syndrome in children and adolescents ? an IDF consensus report
2007 Standout
Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008) : Digest Version
2010
Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease
2013
SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
1999
Association of Kawasaki disease with tropospheric wind patterns
2011
Type 1 and Type 2 Diabetes in Asian and Pacific Islander U.S. Youth
2009
Long-Term Anticoagulation in Kawasaki Disease: Initial Use of Low Molecular Weight Heparin is a Viable Option for Patients with Severe Coronary Artery Abnormalities
2010
Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study
2007
Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan
2006
Ulinastatin, an Elastase Inhibitor, Inhibits the Increased mRNA Expression of Prostaglandin H2Synthase–Type 2 in Kawasaki Disease
2000
Subclinical Atherosclerosis, but Normal Autonomic Function after Kawasaki Disease
2007
Are Patients after Kawasaki Disease at Increased Risk for Accelerated Atherosclerosis?
2007
Multistate and functional protein design using RoseTTAFold sequence space diffusion
2024 StandoutNobel
Kawasaki Disease Patients With Redness or Crust Formation at the Bacille Calmette-Guérin Inoculation Site
2010
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Dobutamine Stress Echocardiography in the Assessment of Suspected Myocardial Ischemia in Children and Young Adults
1997
Revisiting the glomerular charge barrier in the molecular era
2008
Small-Vessel Vasculitis
1997 Standout
Atherosclerosis in Survivors of Kawasaki Disease
2009
Mismatch negativity (MMN), the deviance-elicited auditory deflection, explained
2009 Standout
Computed Tomographic Findings of Kawasaki Disease With Cervical Lymphadenopathy
2012
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Dobutamine Stress Echocardiography in the Evaluation of Young Patients with Kawasaki Disease
2003
The Biophysical Properties of the Aorta Are Altered Following Kawasaki Disease
2013
Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010
2012 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
Epidemiology of Kawasaki Disease in Asia, Europe, and the United States
2012
Gamma globulin re-treatment in Kawasaki disease
1993
Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey
2012
Neonatal Pulmonary Hypertension
2001
The 30-Year Outcome for Patients After Myocardial Infarction Due to Coronary Artery Lesions Caused By Kawasaki Disease
2010
Coronary diameter in normal infants, children and patients with Kawasaki disease
2002
A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value
2010
Phototherapy for Neonatal Jaundice
2008 Standout
Clinical Responses of Patients with Kawasaki Disease to Different Brands of Intravenous Immunoglobulin
2006
Kawasaki Disease in Mongolia: Results From 2 Nationwide Retrospective Surveys, 1996–2008
2011
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Adolescent Kawasaki disease: usefulness of 64-slice CT coronary angiography for follow-up investigation
2011
Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease
1999
The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
2015
Small GTPase Rac1: Structure, Localization, and Expression of the Human Gene
2000
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Trends in Body Mass Index, Blood Pressure, and Serum Lipids in Japanese Children: Iwata Population-Based Annual Screening (1993–2008)
2010
Corticosteroids in the treatment of the acute phase of Kawasaki disease
1999
Diabetic ketoacidosis in children and adolescents with diabetes
2009
Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in Japan
2008
Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease
2014
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Overlooked non-motor symptoms in myasthenia gravis
2012
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
2006
QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities
2009
Early language acquisition: cracking the speech code
2004 Standout
Macrophage activation syndrome in Kawasaki Disease: More common than we thought?
2014
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
2010 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease
2005
Corticosteroids in the initial treatment of Kawasaki disease: Report of a randomized trial
2003
Clinical Features of Patients With Kawasaki Disease Whose Parents Had the Same Disease
2004
Serum Amyloid A and High Density Lipoprotein Participate in the Acute Phase Response of Kawasaki Disease
1997
A critique of the expression of paediatric body composition data
2001
Long-Term Prognostic Impact of Dobutamine Stress Echocardiography in Patients With Kawasaki Disease and Coronary Artery Lesions
2013
The effects of a 3‐year obesity intervention in schoolchildren in Beijing
2007
Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children
2003
Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
2011 Standout
Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches
2013
Sound frequency change detection in fetuses and newborns, a magnetoencephalographic study
2005
Mortality Among Japanese With a History of Kawasaki Disease: Results at the End of 2009
2013
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes
2010
When Children With Kawasaki Disease Grow Up
2009
A Comprehensive Karyotypic Study on Human Hepatocellular Carcinoma by Spectral Karyotyping
2000
Arterial complications associated with cardiac catheterization in pediatric patients with a previous history of kawasaki disease
2008
Serum cholesterol levels during and after Kawasaki disease
1991
Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden
2008
Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease
2004
Type 1 diabetes
2013 Standout
Long-term prognosis of Kawasaki disease: increased cardiovascular risk?
2010
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
2006
Novel and traditional cardiovascular risk factors in children after Kawasaki disease
2004
Compensation for Energy Intake From Fast Food Among Overweight and Lean Adolescents
2004
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Do Kawasaki disease patients without coronary artery abnormalities need a long‐term follow‐up? A myocardial single‐photon emission computed tomography pilot study
2009
A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
2006
Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease
2010
Histopathological characteristics of myocarditis in acute‐phase Kawasaki disease
2012
Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease
2007
Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose
1997
Serial magnetoencephalographic study of fetal and newborn auditory discriminative evoked responses
2006
Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease
2009
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease
2007
Reference values of aortic pulse wave velocity in a large healthy population aged between 3 and 18 years
2012
The mismatch negativity (MMN) in basic research of central auditory processing: A review
2007 Standout
External Validation of a Risk Score to Predict Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease
2010
Plasma fatty acid composition and incident heart failure in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
2008
Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course
2019
Long-term Management of Kawasaki Disease: Implications for the Adult Patient
2013
Early intravenous gamma-globulin treatment for kawasaki disease: The nationwide surveys in Japan
2004
Improved Classification of Coronary Artery Abnormalities Based Only on Coronary Artery z-Scores After Kawasaki Disease
2009
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Normal and anomalous coronary arteries: Definitions and classification
1989
Cockayne syndrome: Clinical features, model systems and pathways
2016
Obesity in children and young people: a crisis in public health
2004 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Magnetoencephalography is feasible for infant assessment of auditory discrimination
2004
Efficacy and Limitation of Infliximab Treatment for Children with Kawasaki Disease Intractable to Intravenous Immunoglobulin Therapy: Report of an Open-label Case Series
2012
Epidemiologic Features of Kawasaki Disease in Japan: Results from the Nationwide Survey in 2005-2006
2008
Assessment of coronary artery aneurysms in paediatric patients with Kawasaki disease by multidetector row CT angiography: feasibility and comparison with 2D echocardiography
2006
Parvovirus B19
2004 Standout
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Guillain-Barré syndrome
2005 Standout
Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses
2015
Cellular senescence: from physiology to pathology
2014 Standout
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Coronary Artery Involvement in Children With Kawasaki Disease
2007
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes
2006
Infections and Kawasaki Disease: Implications for Coronary Artery Outcome
2005
Intravenous immunoglobulin for the treatment of Kawasaki disease in children
2003
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
2012
Coronary Artery Aneurysm Induced by Kawasaki Disease in Children Show Features Typical Senescence
2007
Sequential Follow-Up Results of Catheter Intervention for Coronary Artery Lesions After Kawasaki Disease
2002
Update on new technologies in pediatric echocardiography.
1997
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits
2004 Standout
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
2012
Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
The extracellular matrix at a glance
2010 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
2006
Cardiovascular complications in Kawasaki disease: coronary artery lumen and long-term consequences
2004
Kawasaki Disease: A Brief History
2000
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Interventions for preventing obesity in children
2019 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Pattern of subcutaneous fat during follow‐up of a cohort of N orth I ndian children with K awasaki disease: a preliminary study
2014
Rising Incidence of Type 2 Diabetes in Children in the U.K.
2007
Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle
2004
Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease
2004
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
2010
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Inflammatory Mechanisms in Obesity
2011 Standout
Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease
2010
Critical nodes in signalling pathways: insights into insulin action
2006 Standout
Salicylate for the treatment of Kawasaki disease in children
2006
Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease
2006
Long-Term Outcome of Kawasaki Disease
2008
Feasibility of Optical Coherence Tomography in Children With Kawasaki Disease and Pediatric Heart Transplant Recipients
2014
The Metabolic Syndrome
2008 Standout
Adolescence: a foundation for future health
2012 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2008) - Digest Version -
2010
Mortality Among Persons With a History of Kawasaki Disease in Japan Mortality Among Males With Cardiac Sequelae is Significantly Higher Than That of the General Population
2007
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan
2001
Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
2011
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects
1993
Assessment of Child and Adolescent Overweight and Obesity
2007
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Childhood Guillain-Barré syndrome. MR imaging in diagnosis and follow-up.
2003
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article*1A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography)
2003
Cardiovascular risk factors after Kawasaki disease: A case-control study
2001
Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults
2010
Cardiac Magnetic Resonance Imaging for Noninvasive Assessment of Cardiovascular Disease During the Follow-Up of Patients With Kawasaki Disease
2011
Works of Kensuke Harada being referenced
New criteria of normal serum lipid levels in Japanese children: The nationwide study
2002
Relationship between serum adiponectin level and lipid composition in each lipoprotein fraction in adolescent children
2005
Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)
2005
Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease
2001
Age-Related Acceleration of Endothelial Dysfunction and Subclinical Atherosclerosis in Subjects with Coronary Artery Lesions After Kawasaki Disease
2008
Mortality among patients with a history of Kawasaki disease: The third look
1998
A multicenter, randomized, controlled trial of intravenous gamma globulin therapy in children with acute Kawasaki disease
1994
A study of mismatch negativity in newborns
2001
Changes in apolipoproteins during the acute phase of Kawasaki disease
1995
Assessment of coronary artery abnormalities by multislice spiral computed tomography in adolescents and young adults with Kawasaki disease
2005
Body fat ratios in urban Chinese children
2003
Nitric Oxide and Endothelin 1 during Postnatal Life
1996
The High Level of hCDC10 Gene Expression in Neuroblastoma May Be Associated with Favorable Characteristics of the Tumor
2000
Assessment of body composition measured by bioelectrical impedance in children
1993
Charge Selective Function in Childhood Glomerular Diseases
2006
Coronary risks after high‐dose γ‐globulin in children with Kawasaki disease
2000
Cationic charge-preferential IgG reabsorption in the renal proximal tubules
2004
Mortality Among Persons with a History of Kawasaki Disease in Japan: Existence of Cardiac Sequelae Elevated the Mortality.
2000
Urine Glucose Screening Program at Schools in Japan to Detect Children with Diabetes and Its Outcome-Incidence and Clinical Characteristics of Childhood Type 2 Diabetes in Japan
2007
Myasthenia gravis with alopecia totalis
2007
Detection of myocardial contractile reserve by low-dose dobutamine quantitative gated single-photon emission computed tomography in patients with Kawasaki disease and severe coronary artery lesions
2003
Cockayne syndrome with recurrent acute tubulointerstitial nephritis
2006
Non-invasive measurement of coronary flow reserve in children with Kawasaki disease
2002
No Clinical Correlation Between Bilirubin Levels and Severity of Retinopathy of Prematurity
2002
Plasma palmitoleic acid content and obesity in children
2005
Magnetic resonance imaging of the cauda equina in two patients with Guillain‐Barré syndrome
1997
Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease
1996
Intravenous γ‐Globulin Treatment in Kawasaki Disease
1991
Mortality Among Persons With a History of Kawasaki Disease in Japan
2002
A fatal case of ruptured giant coronary artery aneurysm
2005
Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazole and recombinant human granulocyte‐colony stimulating factor
1996
Annual Incidence and Clinical Characteristics of Type 2 Diabetes in Children as Detected by Urine Glucose Screening in the Tokyo Metropolitan Area
2005
Recent Change in the Annual Incidence of Childhood Type 2 Diabetes in the Tokyo Metropolitan Area
2007
Association of Atrial Arrhythmia and Sinus Node Dysfunction in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
2007
Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease (Acute mucocutaneous lymph node syndrome).
1982
Waist-to-height Ratio is the Best Predictor of Cardiovascular Disease Risk Factors in Japanese Schoolchildren
2002
Karyotypic Analyses of Hepatoblastoma
1999
Noninvasive Assessment of the Early Progression of Atherosclerosis in Adolescents With Kawasaki Disease and Coronary Artery Lesions
2001
Immunoreactive Polymorphonuclear Leukocyte Elastase in Complex with Alphal‐Antitrypsin in Kawasaki Disease
1987
Detection of Coronary Artery Aneurysms, Stenoses and Occlusions by Multislice Spiral Computed Tomography in Adolescents With Kawasaki Disease
2003
Estimation of “Selective” Intravenous Gamma Globulin Treatment Indicated by Harada Score
2003
Association of Sinus Node Dysfunction, Atrioventricular Node Conduction Abnormality and Ventricular Arrhythmia in Patients With Kawasaki Disease and Coronary Involvement
2008
Myocardial Infarction and Left Coronary Ostial Stenosis in Infancy Simulating Anomalous Origin of the Left Coronary Artery
1980